These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12039901)

  • 1. Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori.
    Tanaka M; Isogai E; Isogai H; Hayashi S; Hirose K; Kimura K; Sugiyama T; Sato K
    J Antimicrob Chemother; 2002 Jun; 49(6):1039-40. PubMed ID: 12039901
    [No Abstract]   [Full Text] [Related]  

  • 2. New quinolone compounds from Pseudonocardia sp. with selective and potent anti-Helicobacter pylori activity: taxonomy of producing strain, fermentation, isolation, structural elucidation and biological activities.
    Dekker KA; Inagaki T; Gootz TD; Huang LH; Kojima Y; Kohlbrenner WE; Matsunaga Y; McGuirk PR; Nomura E; Sakakibara T; Sakemi S; Suzuki Y; Yamauchi Y; Kojima N
    J Antibiot (Tokyo); 1998 Feb; 51(2):145-52. PubMed ID: 9544935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of new quinolones against Helicobacter pylori.
    Carbone M; Fera MT; Cecchetti V; Tabarrini O; Losi E; Cusumano V; Teti G
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2790-2. PubMed ID: 9420062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro.
    Midolo PD; Turnidge JD; Lambert JR
    J Antimicrob Chemother; 1997 Mar; 39(3):331-7. PubMed ID: 9096182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo action of novel alkyl methyl quinolone alkaloids against Helicobacter pylori.
    Tominaga K; Higuchi K; Hamasaki N; Hamaguchi M; Takashima T; Tanigawa T; Watanabe T; Fujiwara Y; Tezuka Y; Nagaoka T; Kadota S; Ishii E; Kobayashi K; Arakawa T
    J Antimicrob Chemother; 2002 Oct; 50(4):547-52. PubMed ID: 12356800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents.
    Sakurai N; Sano M; Hirayama F; Kuroda T; Uemori S; Moriguchi A; Yamamoto K; Ikeda Y; Kawakita T
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2185-90. PubMed ID: 9873510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Helicobacter pylori activity of quinolone alkaloids from Evodiae fructus.
    Rho TC; Bae EA; Kim DH; Oh WK; Kim BY; Ahn JS; Lee HS
    Biol Pharm Bull; 1999 Oct; 22(10):1141-3. PubMed ID: 10549874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance of Helicobacter pylori: memorandum from a meeting at the Sixth International Workshop on Campylobacter, Helicobacter, and Related Organisms.
    Westblom TU; Unge P
    J Infect Dis; 1992 May; 165(5):974-5. PubMed ID: 1569352
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
    Malizia T; Tejada M; Marchetti F; Favini P; Pizzarelli G; Campa M; Senesi S
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():29-35. PubMed ID: 9579710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Helicobacter pylori: what schemes of eradication are essential today?].
    Maev IV; Samsonov AA; Golubev NN
    Ter Arkh; 2011; 83(8):41-4. PubMed ID: 21961331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori.
    Tharmalingam N; Port J; Castillo D; Mylonakis E
    Sci Rep; 2018 Feb; 8(1):3701. PubMed ID: 29487357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antimotility action of a trifluoromethyl ketone on some gram-negative bacteria.
    Spengler G; Molnár A; Klausz G; Mándi Y; Kawase M; Motohashi N; Molnár J
    Acta Microbiol Immunol Hung; 2004; 51(3):351-8. PubMed ID: 15571074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori therapy: a paradigm shift.
    Graham DY; Dore MP
    Expert Rev Anti Infect Ther; 2016 Jun; 14(6):577-85. PubMed ID: 27077447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones.
    Sánchez JE; Sáenz NG; Rincón MR; Martín IT; Sánchez EG; Martínez MJ
    J Antimicrob Chemother; 2000 Aug; 46(2):283-5. PubMed ID: 10933654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Helicobacter pylori eradication: how to teach an old dog new tricks!
    Zullo A; De Francesco V; Hassan C
    J Clin Gastroenterol; 2012 Apr; 46(4):259-61. PubMed ID: 22395061
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there any effect of sequential eradication therapy of helicobacter pylori on functional dyspepsia symptom resolution?
    Sarikaya M; Filik L; Doğan Z; Ergül B
    Acta Gastroenterol Belg; 2013 Dec; 76(4):448-9. PubMed ID: 24592555
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis of Helicobacter pylori Infection in the Proton Pump Inhibitor Era.
    Calvet X
    Gastroenterol Clin North Am; 2015 Sep; 44(3):507-18. PubMed ID: 26314665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis.
    Marin AC; Nyssen OP; McNicholl AG; Gisbert JP
    Drugs; 2017 May; 77(7):765-776. PubMed ID: 28361211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled study of a novel triple nitazoxanide (NTZ)-containing therapeutic regimen versus the traditional regimen for eradication of Helicobacter pylori infection.
    Shehata MA; Talaat R; Soliman S; Elmesseri H; Soliman S; Abd-Elsalam S
    Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28524341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial effect of garlic and omeprazole on Helicobacter pylori.
    Jonkers D; van den Broek E; van Dooren I; Thijs C; Dorant E; Hageman G; Stobberingh E
    J Antimicrob Chemother; 1999 Jun; 43(6):837-9. PubMed ID: 10404325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.